NSE: CONCORDBIO - Concord Biotech Limited

Altı ay boyunca karlılık: +39.63%
Temettü getirisi: 0.00%

Promosyon programı Concord Biotech Limited


Şirket hakkında Concord Biotech Limited

Concord Biotech Limited, a biopharma company, engages in the research and development, manufacturing, marketing, and sale of pharmaceutical products in India and internationally. The company provides fermentation based active pharmaceutical ingredients in immunosuppressants, anti-bacterial, oncology, antifungal, and other therapeutic areas.

daha fazla ayrıntı
It also offers tacrolimus, mycophenolate mofetil, mycophenolate sodium, cyclosporine, sirolimus, and pimecrolimus for immunosuppressants therapeutic segment; temsirolimus, everolimus, romidepsin, mitomycin, midostaurin, dactinomycin, staurosporin, mitoguazone, and everolimus premix for oncology therapeutic segment; mupirocin, mupirocin calcium, polymyxin B sulfate, fidaxomicin, vancomycin hydrochloride, and teicoplanin for anti-bacterial applications; anidulafungin, caspofungi, micafungin sodium, amphotericin B, and nystatin for anti-fungal therapeutic segment; and lovastatin, pravastatin sodium, and enzymes for other applications. In addition, it provides contract research and manufacturing services in the areas of fermentation and semi-synthesis products. Concord Biotech Limited was incorporated in 1984 and is based in Ahmedabad, India.

Industry Biotechnology
Sector Health Care
Валюта inr
Сайт https://www.concordbiotech.com
Цена ао 2047.8
Günlük fiyat değişimi: 0% (2047.8)
Haftalık fiyat değişimi: -14.04% (2382.35)
Aylık fiyat değişimi: +20.06% (1705.6)
3 ayda fiyat değişimi: +31.16% (1561.25)
Altı ayda fiyat değişimi: +39.63% (1466.6)
Yıllık fiyat değişimi: +104.68% (1000.5)
3 yılda fiyat değişimi: 0% (2047.8)
5 yılda fiyat değişimi: 0% (2047.8)
10 yılda fiyat değişimi: 0% (2047.8)
Yılbaşından bu yana fiyat değişimi: +32.43% (1546.35)

Hafife alma

İsim Anlam Seviye
P/S 0 0
P/BV 0 0
P/E 0 0
EV/EBITDA 0 0
Toplam: 2.5

Yeterlik

İsim Anlam Seviye
ROA, % 0 0
ROE, % 0 0
Toplam: 0

Temettüler

İsim Anlam Seviye
Div yield, % 0 0
DSI 0 0
Toplam: 0.6714

Görev

İsim Anlam Seviye
Debt/EBITDA 0 10
Toplam: 10

Büyüme dürtüsü

İsim Anlam Seviye
karlılık Revenue, % 66.53 8
karlılık Ebitda, % 77.79 8
karlılık EPS, % 0 0
Toplam: 4.4

Süpervizör İş unvanı Ödeme Doğum yılı
Mr. Sudhir Jairam Vaid Chairman & MD 1952 (73 yıl)
Mr. Ankur Vaid Joint MD, CEO & Director 1982 (43 yıl)
Mr. Lalit Sethi Chief Financial Officer
Mr. Prakash Lalchand Sajnani Company Secretary, Compliance Officer & Assistant VP of Finance
Mr. Devang Bhatt VP of Sales & Marketing and Head of Limbasi Plant-3
Mr. Manoj Kumar VP of Formulation Division & Head of Valthera Unit-2
Sundeep Bengani General Manager, International Business Development

Adres: India, Ahmedabad, 16th Floor B-Wing - Google haritalarda aç, Yandex haritalarını aç
Web sitesi: https://www.concordbiotech.com